Off-site, modular construction minimizes disruption to
building timelines and logistical delays, ensuring systematic delivery of new facilities,
this is particularly beneficial within the healthcare industry, where speed,
sanitation and sterility are crucial
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Modular Facilities in
Pharmaceutical and Biotechnology Market”
The
report features an extensive study of the current market landscape and future
potential of the players engaged in offering services for modular facility
construction for biotechnology and pharmaceutical industries. The study presents
an in-depth analysis, highlighting the capabilities of various stakeholders
engaged in this domain. Amongst other elements, the report features:
§
An in-depth review of the market landscape of players that
offer services for modular facility construction for biotechnology and
pharmaceutical industries, along with the details of certifications obtained
and COVID-19 related initiatives undertaken by modular service providers.
§
A review of the market landscape of modular cleanrooms
along with information on their year of establishment, company size, location
of headquarters, type of industry served, type of modular cleanrooms, type of
modular cleanroom components. It also includes details related to regulatory
approvals and certifications.
§
An analysis of the partnerships that have been inked by
stakeholders in this domain, during the period between 2012 and 2021.
§
An in-depth analysis of modular projects undertaken across
key geographical regions, featuring information on type of facility, facility
area, most active manufacturers, most active clients, location of
facility.
§
An insightful analysis on facility construction trends in
the pharmaceutical industry for the last five years, highlighting facility
construction projects established by top 20 pharma / biotech players.
§
Elaborate profiles of key players that provide a wide range
of modular manufacturing solutions to pharmaceutical and biotechnology
industries.
§
An in-depth review of emerging trends, including processing
technologies with modular facilities, the shift towards smaller,
multi-purpose modular facilities, and technological advancements in modular
construction processes.
§
A detailed discussion on the various growth drivers and
trends related to modular solutions in emerging markets by pharmaceutical /
biopharmaceutical CMOs.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
To Request Sample Pages - https://www.rootsanalysis.com/reports/178/request-sample.html
§ Type
of Modular Construct
§ Hybrid
Skid
§ Plug-and-Play
§ Skid-Mounted
§ Truckable
§ Others
§ Type
of Construction Component
§ Base
Building
§ Electrical
System
§ Mechanical
System
§ Process
Equipment
§ Process
Piping
§ Process
Utilities
§ Other
Components
§ Purpose
of Facility
§ Aseptic
Filling
§ Manufacturing
§ Research
and Development
§ Others
§ Facility
Area
§ Very
Small
§ Small
§ Mid-Sized
§ Large
§ Very
Large
§ Scale
of Operation
§ Clinical
§ Commercial
§ Type
of Industry
§ Pharmaceutical
§ Biotechnology
§ Type
of Product
§ Biosimilars
§ Cell
and Gene Therapies
§ Monoclonal
Antibodies
§ Vaccines
§ Other
Products
§
Type of Facility
§
New Facility
§
Facility Expansions
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia
§ Middle
East and North Africa
§ Latin
America
§ Rest
of the World
Download Free Insights now - https://www.rootsanalysis.com/reports/178/free-insights.html
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
Alan de Zayas (Modular Building
Manufacturing and Construction Team, Avon Modular Construction)
§
François Abiven (Executive Vice-President Global Business
Unit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)
§
Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)
§
Pär Almhem (President, Modwave)
§
Sulogna Roy (Ex Sales Manager, Zeton)
§
Vernon Solomon (Specialist in Modular Design for Cleanrooms
and Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)
Key
companies covered in the report
§
Cytiva
§ G-CON Manufacturing
§ Pharmadule Morimatsu
§ NNE
§ IPM Technologies
§ KeyPlants
§ Germfree Laboratories
§ ModuleCO Pharma
For
more information, please click on the following link
https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html
You
may also be interested in the following titles:
1.
Vaccine Contract
Manufacturing Market (3rd Edition), 2021-2030
2.
Biopharmaceutical CROs
Market, 2021-2030
3.
Continuous Manufacturing
Equipment Providers Market, 2021-2030
4.
DNA-Encoded
Libraries: Platforms and Services Market
5.
Antibody
Discovery: Services and Platforms Market (2nd Edition), 2018-2028
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
